Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavík Study
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsThrainsdottir, Inga S
MetadataShow full item record
CitationEur J Cardiovasc Prev Rehabil. 2005, 12(5):465-71
ÚtdrátturBACKGROUND: The risk of cardiovascular disease increases progressively with increasing blood glucose from levels well below the diabetic threshold. In the Reykjavík Study the relationship between heart failure and abnormal glucose regulation was already apparent at the level of impaired glucose tolerance. The aim of this study was to determine the prognosis of participants with any glucose abnormality and heart failure and to test whether the combination of these conditions may adversely affect the subsequent prognosis. DESIGN: A prospective population-based study. METHODS: Data from the first visit of 19 381 participants were used. Participants were divided into groups according to their glycaemic and heart failure level, and comparisons were made between the groups and disease-free participants serving as a reference group. The risk of mortality and morbidity was calculated with adjustments for main cardiovascular risk factors and ischaemic heart disease. RESULTS: Participants in the reference group were younger, had lower body mass indices and more seldom a history of myocardial infarction compared with diseased groups. Mortality was lowest in the reference group (P<0.0001) increasing to a maximum in participants with the combination of glucose abnormality and heart failure. Prognostically, the mortality risk associated with abnormal glucose regulation was increased but was lower than the risk of diabetes. The risk of a new myocardial infarction was highest in participants with diabetes [hazard ratio (HR) 1.6; 95% confidence interval (CI) 1.3-2.0] or diabetes in combination with heart failure (HR 1.8; CI 1.1-2.7). CONCLUSIONS: Heart failure or glucose abnormalities are related to increased morbidity and mortality. The combination of glucose abnormality and heart failure did, however, not add further to the unfavourable prognosis in the presence of ischaemic heart disease.
Lu00FDsingTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- The association between glucose abnormalities and heart failure in the population-based Reykjavik study.
- Authors: Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K, Sigurdsson G, Rydén L
- Issue date: 2005 Mar
- Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
- Authors: Høfsten DE, Løgstrup BB, Møller JE, Pellikka PA, Egstrup K
- Issue date: 2009 May
- Diabetes mellitus, blood glucose and the risk of heart failure: A systematic review and meta-analysis of prospective studies.
- Authors: Aune D, Schlesinger S, Neuenschwander M, Feng T, Janszky I, Norat T, Riboli E
- Issue date: 2018 Nov
- Increasing glucose levels and BMI predict future heart failure experience from the Reykjavík Study.
- Authors: Thrainsdottir IS, Aspelund T, Gudnason V, Malmberg K, Sigurdsson G, Thorgeirsson G, Hardarson T, Rydén L
- Issue date: 2007 Oct
- Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
- Authors: Smaradottir MI, Ritsinger V, Gyberg V, Norhammar A, Näsman P, Mellbin LG
- Issue date: 2017 Mar